1.
Rebaz M. Ali, Fahmi H. Kakamad, Hiwa O. Abdullah, Shalaw H. Abdulla, Shaho F. Ahmed, Bnar J. Hama Amin, et al. Pembrolizumab (Anti-PD-1) Immunotherapy in Malignant Pleural Mesothelioma: A Systematic Review of the Current Literature. Barw Medical Journal. 2023 Jul. 27;. https://www.barwmedical.com/index.php/BMJ/article/view/34